Year To Quarter End Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7613644

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-556,425,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-534,474,000 JPY
-1,129,612,000 JPY
-1,111,032,000 JPY
-1,129,612,000 JPY
-1,129,612,000 JPY
-1,129,612,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-652,000 JPY
376,000 JPY
Deferred gains or losses on hedges
7,754,000 JPY
-1,176,000 JPY
Foreign currency translation adjustment
16,396,000 JPY
-8,058,000 JPY
Other comprehensive income
23,498,000 JPY
-8,858,000 JPY
Comprehensive income
-510,976,000 JPY
-1,119,890,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-510,976,000 JPY
-1,119,890,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.